Colgate-Palmolive (NYSE:CL) Shares Sold by Cardinal Strategic Wealth Guidance

Cardinal Strategic Wealth Guidance reduced its holdings in Colgate-Palmolive (NYSE:CL) by 8.2% during the 4th quarter, Holdings Channel reports. The fund owned 5,333 shares of the company’s stock after selling 475 shares during the period. Cardinal Strategic Wealth Guidance’s holdings in Colgate-Palmolive were worth $485,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC grew its position in Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after buying an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after buying an additional 557,492 shares in the last quarter. Barclays PLC raised its position in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the period. Finally, FMR LLC boosted its stake in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $85.94 on Tuesday. The company has a market capitalization of $70.21 billion, a P/E ratio of 24.41, a P/E/G ratio of 4.12 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The stock’s fifty day moving average is $90.36 and its two-hundred day moving average is $96.77.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm earned $0.87 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CL shares. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. UBS Group cut their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.